Literature DB >> 18491982

Ocular novel drug delivery: impacts of membranes and barriers.

Jaleh Barar1, Ali Reza Javadzadeh, Yadollah Omidi.   

Abstract

BACKGROUND: Ocular drug delivery is an extremely challenging area due to its restrictive barrier functionalities.
OBJECTIVE: Drug transport via corneal/non-corneal routes involves several intricate biological processes such as drug penetration across the ocular barriers and transfer to the anterior or posterior chambers, thus the influence of these processes on the pharmacotherapy of the eye should be fully addressed.
METHODS: To pursue the impacts of such impediments in novel drug therapy, recent publications were reviewed regarding advanced strategies such as nanomedicines.
CONCLUSION: The ocular barriers are highly specialized and selectively control the inward/outward traverse of compounds, hence a better understanding of these biological obstacles would provide a platform to advance ophthalmic drug therapy towards specified delivery/targeting with minimal adverse consequences.

Mesh:

Year:  2008        PMID: 18491982     DOI: 10.1517/17425247.5.5.567

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  53 in total

1.  Sustained Release of a Monoclonal Antibody from Electrochemically Prepared Mesoporous Silicon Oxide.

Authors:  Jennifer S Andrew; Emily J Anglin; Elizabeth C Wu; Michelle Y Chen; Lingyun Cheng; William R Freeman; Michael J Sailor
Journal:  Adv Funct Mater       Date:  2010-09-08       Impact factor: 18.808

Review 2.  Ocular drug delivery.

Authors:  Ripal Gaudana; Hari Krishna Ananthula; Ashwin Parenky; Ashim K Mitra
Journal:  AAPS J       Date:  2010-05-01       Impact factor: 4.009

Review 3.  Nanocarriers of nanotechnology in retinal diseases.

Authors:  Ali M Al-Halafi
Journal:  Saudi J Ophthalmol       Date:  2014-03-05

Review 4.  Targeted Ocular Drug Delivery with Pharmacokinetic/Pharmacodynamic Considerations.

Authors:  Jie Shen; Guang Wei Lu; Patrick Hughes
Journal:  Pharm Res       Date:  2018-09-25       Impact factor: 4.200

5.  Impacts of nanomedicines in ocular pharmacotherapy.

Authors:  Ailar Nakhlband; Jaleh Barar
Journal:  Bioimpacts       Date:  2011-06-09

6.  Barrier functionality of porcine and bovine brain capillary endothelial cells.

Authors:  Ailar Nakhlband; Yadollah Omidi
Journal:  Bioimpacts       Date:  2011-09-30

7.  Planar microdevices enhance transport of large molecular weight molecules across retinal pigment epithelial cells.

Authors:  Jennifer S Wade; Tejal A Desai
Journal:  Biomed Microdevices       Date:  2014-08       Impact factor: 2.838

Review 8.  A comprehensive insight on ocular pharmacokinetics.

Authors:  Vibhuti Agrahari; Abhirup Mandal; Vivek Agrahari; Hoang M Trinh; Mary Joseph; Animikh Ray; Hicheme Hadji; Ranjana Mitra; Dhananjay Pal; Ashim K Mitra
Journal:  Drug Deliv Transl Res       Date:  2016-12       Impact factor: 4.617

Review 9.  Advances in the use of prodrugs for drug delivery to the eye.

Authors:  Pranjal Taskar; Akshaya Tatke; Soumyajit Majumdar
Journal:  Expert Opin Drug Deliv       Date:  2016-07-21       Impact factor: 6.648

Review 10.  Ocular delivery of macromolecules.

Authors:  Yoo Chun Kim; Bryce Chiang; Xianggen Wu; Mark R Prausnitz
Journal:  J Control Release       Date:  2014-07-03       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.